Loading…
Rajgor Castor Derivatives (RCDL)₹21.80+4.31%Edible Oil
In the Mar 2026 quarter (standalone), Rajgor Castor Derivatives reported sales of ₹591 Cr, up 70.8% from Mar 2025, and net profit of ₹11.01 Cr, up 57.1% year on year. For the year to Mar 2026, sales were ₹870 Cr and net profit ₹13.02 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 204 | 191 | 373 | 277 | 346 | 278 | 591 |
| Expenses | 191 | 181 | 361 | 271 | 331 | 272 | 574 |
| Operating Profit | 12.01 | 7.99 | 12.01 | 5.01 | 16.01 | 6.01 | 17.01 |
| OPM % | 6.0% | 4.3% | 3.2% | 2.0% | 4.5% | 2.2% | 2.9% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 0.00 | 2.99 |
| Interest | 1.01 | 3.01 | 3.01 | 3.01 | 5.02 | 3.01 | 4.01 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Profit before tax | 11.04 | 5.02 | 9.03 | 2.01 | 12.04 | 2.01 | 15.05 |
| Tax % | 24.9% | 30.9% | 26.9% | 16.0% | 39.0% | 24.0% | 26.0% |
| Net Profit | 8.01 | 3.01 | 6.01 | 2.01 | 7.01 | 2.01 | 11.01 |
| EPS (Rs) | 36.97 | 2.25 | 2.69 | 0.73 | 3.06 | 0.69 | 4.62 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 113 | 13.96 | 9.97 | 39.88 | 428 | 563 | 624 | 870 |
| Expenses | 110 | 12.95 | 9.97 | 36.87 | 415 | 543 | 602 | 846 |
| Operating Profit | 2.01 | 1.01 | 0.00 | 3.01 | 12.01 | 20.02 | 21.01 | 23.01 |
| OPM % | 2.0% | 8.9% | −0.8% | 7.0% | 2.7% | 3.6% | 3.4% | 2.7% |
| Other Income | 0.00 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 | 1.99 | 2.99 |
| Interest | 1.01 | 2.01 | 2.01 | 2.01 | 2.01 | 5.02 | 8.03 | 8.02 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 |
| Profit before tax | 0.00 | −1.01 | −3.01 | 0.00 | 9.03 | 14.05 | 14.05 | 17.06 |
| Tax % | 28.0% | −25.0% | −29.0% | −62.1% | 35.9% | 27.9% | 35.0% | 26.0% |
| Exceptional items | 0.00 | −0.02 | −0.05 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.00 | −1.01 | −2.01 | 1.01 | 6.01 | 10.02 | 9.02 | 13.02 |
| EPS (Rs) | 30.67 | −92.01 | −153.28 | 44.30 | 25.90 | 4.10 | 3.78 | 5.30 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 27.1% | 0.0% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.11 | 0.11 | 0.11 | 0.11 | 2.01 | 23.93 | 23.92 | 23.93 |
| Reserves | 3.99 | 2.99 | 0.99 | 1.99 | 21.91 | 49.78 | 58.76 | 70.74 |
| Borrowings | 17.96 | 18.93 | 22.96 | 17.95 | 44.82 | 46.82 | 43.81 | 75.72 |
| Other Liabilities | 4.03 | 4.02 | 1.01 | 16.95 | 9.95 | 65.68 | 27.86 | 105 |
| Total Liabilities | 26.97 | 26.93 | 25.95 | 37.88 | 77.69 | 187 | 154 | 276 |
| Fixed Assets | 17.97 | 21.95 | 20.97 | 19.96 | 19.95 | 20.96 | 19.95 | 19.95 |
| CWIP | 4.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 |
| Other Assets | 3.99 | 3.98 | 3.98 | 16.92 | 57.74 | 164 | 133 | 255 |
| Inventories | 0.00 | 0.00 | 0.00 | 13.01 | 19.01 | 24.01 | 29.01 | 39.01 |
| Trade receivables | 0.00 | 0.99 | 0.00 | 0.00 | 13.97 | 98.82 | 80.91 | 167 |
| Cash & equivalents | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.99 | 0.99 | 12.96 |
| Total Assets | 26.97 | 26.93 | 25.95 | 37.88 | 77.69 | 187 | 154 | 276 |
| Mar 2019 | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 2.01 | 3.01 | 7.03 | −40.14 | −34.11 | 11.04 | −14.04 |
| Cash from investing activity | −23.06 | −1.01 | 0.00 | −1.01 | −4.01 | 1.01 | −9.02 |
| Cash from financing activity | 20.91 | −1.99 | −6.97 | 40.85 | 37.88 | −11.95 | 23.89 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 |
| Capex | 21.95 | 1.40 | 0.14 | 1.07 | 2.89 | 0.60 | 1.18 |
| Free cash flow | −20.08 | 1.01 | 7.02 | −41.14 | −37.12 | 10.04 | −15.06 |
| CFO / OP % | 95.0% | 226.1% | 273.1% | −347.9% | −163.0% | 64.1% | −44.9% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 18 | 3 | 3 | 13 | 65 | 48 | 71 |
| Inventory days | 0 | 4 | 9 | 130 | 18 | 18 | 19 | 18 |
| Days payable | — | 2 | 5 | 10 | 6 | 31 | 7 | 30 |
| Cash conversion cycle | 0 | 21 | 6 | 122 | 26 | 52 | 60 | 59 |
| Working capital days | −2 | −23 | −470 | −129 | 8 | 36 | 37 | 27 |
| ROCE % | — | 4.0% | −1.0% | 11.9% | 22.9% | 19.9% | 16.9% | 16.9% |
For the Mar 2026 quarter, Rajgor Castor Derivatives reported sales of ₹591 Cr, up 70.8% year on year and net profit of ₹11.01 Cr, up 57.1% year on year. The operating margin was 2.9%.
Rajgor Castor Derivatives' sales for the year to Mar 2026 were ₹870 Cr.
Net profit for the year to Mar 2026 was ₹13.02 Cr. Earnings per share over the same trailing period were ₹5.30.
Rajgor Castor Derivatives reported borrowings of ₹75.72 Cr at Mar 2026, against cash and equivalents of ₹12.96 Cr.
Cash from operations was −₹14.04 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹15.06 Cr.